Clinical Trial Update: Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating sub-retinal transplantation of retinal pigment epithelial cells for dry age-related macular degeneration has been withdrawn. No furth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• RPE Cell Transplant

Snippet

Sponsor: Astellas Institute for Regenerative Medicine | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: WITHDRAWN